Boston Therapeutics Appoints Three to Management Positions
10 déc. 2013 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Dec 10, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovative developer of drugs that address diabetes using complex...
Boston Therapeutics Appoints Conroy Chi-Heng Cheng and S. Colin Neill to Board of Directors
04 déc. 2013 12h47 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Dec 4, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovative developer of drugs that address diabetes using...
Boston Therapeutics Presents at the Elsevier Therapeutic Area Partnerships 2013 Conference in Boston on November 19
18 nov. 2013 07h38 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Nov 18, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovative developer of drugs that address diabetes using complex...
Boston Therapeutics Exhibits at Obesity Week 2013 Conference
14 nov. 2013 07h05 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Nov 14, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovator developer of drugs that address diabetes using complex...
Boston Therapeutics Reports Corporate Update and Financial Results for the Third Quarter and Nine Months Ended September 30, 2013
13 nov. 2013 16h05 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Nov 13, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovator of drugs that address diabetes using complex...
Boston Therapeutics Enrolls Patients With Type 2 Diabetes in a Phase IIb Clinical Trial With PAZ320
12 nov. 2013 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Nov 12, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovator in designing drugs that address diabetes using complex...
Boston Therapeutics to Present at the Livingston Securities Advanced and Nano Life Sciences Summit
16 oct. 2013 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Oct 16, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a leading developer of drugs that address diabetes using complex...
Boston Therapeutics Initiates Research Study on PAZ320 at University of Minnesota
15 oct. 2013 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Oct 15, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of drugs based on complex carbohydrate chemistry to treat...
Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants
03 oct. 2013 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Oct 3, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of drugs based on complex carbohydrate chemistry to treat...
Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants
09 sept. 2013 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Sep 9, 2013) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of drugs based on complex carbohydrate chemistry to treat...